Jump to content

Granulomatous prostatitis: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
+infobox with image
No edit summary
Line 13: Line 13:
}}
}}


'''Granulomatous prostatitis''' is an uncommon disease of the [[prostate]], an [[exocrine gland]] of the [[male]] [[reproductive system]]. It is a form of [[prostatitis]], i.e. [[inflammation]] of the prostate, resulting from infection (bacterial, viral, or fungal), the [[BCG]] therapy, [[malacoplakia]] or systemic granulomatous diseases which involve the prostate.
'''Granulomatous prostatitis''' is an uncommon disease of the [[prostate]], an [[exocrine gland]] of the [[male]] [[reproductive system]]. It is a form of [[prostatitis]], i.e. [[inflammation]] of the prostate, resulting from infection (bacterial, viral, or fungal), the [[BCG]] therapy, [[malacoplakia]] or systemic granulomatous diseases which involve the prostate. THERAPY: UROBAC is an OTC nutraceutical compound that is designed to specifically reverse the symptoms of and the structural damage that comprises BPH, Chronic Prostatitis & CPPSIII. Clinical studies were done by renowned NIH prostatitis researcher Daniel Shoskes, MD at the Cleveland Clinic and Urobac study results were published in The Journal of Urology. Other confirmatory research was done at NASA & Baylor. Quit suffering and eradicate your BPH & CP! Read the studies and obtain Urobac at: http://www.nanobiotech.us/urobac.





Revision as of 13:12, 22 November 2011

Granulomatous prostatitis

Granulomatous prostatitis is an uncommon disease of the prostate, an exocrine gland of the male reproductive system. It is a form of prostatitis, i.e. inflammation of the prostate, resulting from infection (bacterial, viral, or fungal), the BCG therapy, malacoplakia or systemic granulomatous diseases which involve the prostate. THERAPY: UROBAC is an OTC nutraceutical compound that is designed to specifically reverse the symptoms of and the structural damage that comprises BPH, Chronic Prostatitis & CPPSIII. Clinical studies were done by renowned NIH prostatitis researcher Daniel Shoskes, MD at the Cleveland Clinic and Urobac study results were published in The Journal of Urology. Other confirmatory research was done at NASA & Baylor. Quit suffering and eradicate your BPH & CP! Read the studies and obtain Urobac at: http://www.nanobiotech.us/urobac.